Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Post by Baylor1965on May 11, 2011 4:59pm
414 Views
Post# 18562279

Did you know that

Did you know that
Did you know that V.Wee Yong Lab in Calgary worked on endogenous progenitor cell repair in multiple sclerosis along side Weiss & Co?


Stem Cell Network of the National Centre of Excellence, on: Endogenous progenitor cell repair

in multiple sclerosis. Team members: J Antel, F Costello, L Metz, S Weiss (PI), VW Yong, 2008 – 2011.

$783,600 for the whole team. My portion is $60,000 per year

https://www.vweeyong.com/research.htm

Did you know that Angelika Goncalves DaSilva (SCT's investor's contact) studied for her PhD at this lab?

https://www.vweeyong.com/dasilva.htm


Baylor

Bullboard Posts